Exploring the Intersection of Autoimmune Disorders and Women's Health: A Cross-Sectional Study of Gynecological and Systemic Manifestations
DOI:
https://doi.org/10.51699/cajmns.v5i4.2911Keywords:
Autoimmune Disorders, Women’s Health, Gynecological Symptoms, Systemic Symptoms, Quality of Life, Treatment Outcomes, Risk FactorsAbstract
As far as women are concerned, autoimmune disorders pose an important threat to their health, with both gynecological and systemic manifestations. To examine autoimmune disorders, treatment modalities, and post-treatment outcomes in females with autoimmune disorders. Gynecological and systemic manifestations that occur during a 12-month follow-up are of interest. One hundred five female patients diagnosed with different autoimmune disorders were included in this cross-sectional study conducted in Al-Diwaniyah, Iraq, from April 2023 to April 2024. Baseline data were collected on various clinical characteristics, types of autoimmune diseases, and treatment modalities employed to treat the patients. Assessment of symptoms and quality of life was done for all patients through standardized questionnaires at baseline and at 1, 3, 7, and 12 months following treatment. Most of the cohort were women aged 20-40 years (52.4%), with the mean BMI being 24.5 ± 3.2 kg/m². Hypertension and asthma stood foremost among the comorbidities, being 23.8% and 17.1% prevalent, respectively. Of autoimmune disorders, the most common ones were rheumatoid arthritis, 43 (40.95), and lupus, 20 (19.0). Among gynecological symptoms were more irregular menstrual cycles (47.6%), whereas fatigue (66.7%) was the common systemic symptom. Response to treatment at 12 months yielded the most significant reduction in symptoms and improvement in quality of life. This study articulates the severe effects that autoimmune disorders pose on systemic and gynecological health in women. In this case, timely diagnosis and directed therapy lead to better outcomes and improved quality of life.
References
E. F. McCarthy, "The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas," The Iowa Orthopaedic Journal, vol. 26, pp. 154, 2006.
S. T. Ngo, F. J. Steyn, and P. A. McCombe, "Gender differences in autoimmune disease," Frontiers in Neuroendocrinology, vol. 35, no. 3, pp. 347-369, 2014.
C. C. Whitacre, "Sex differences in autoimmune disease," Nature Immunology, vol. 2, no. 9, pp. 777-780, 2001.
K. H. Costenbader and E. W. Karlson, "Epstein–Barr virus and rheumatoid arthritis: is there a link?" Arthritis Research & Therapy, vol. 8, pp. 1-7, 2006.
E. C. Somers, W. Marder, P. Cagnoli, E. E. Lewis, P. DeGuire, C. Gordon, et al., "Population‐based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program," Arthritis & Rheumatology, vol. 66, no. 2, pp. 369-378, 2014.
G. S. Cooper and B. C. Stroehla, "The epidemiology of autoimmune diseases," Autoimmunity Reviews, vol. 2, no. 3, pp. 119-125, 2003.
N. H. S. Al-Mawaliyah, "Investigation of an association between human leukocyte antigens and systemic lupus erythematosus among Omani patients," Sultan Qaboos University, Oman, 2017.
M. Mosca, C. Tani, M. Aringer, S. Bombardieri, D. Boumpas, R. Brey, et al., "EULAR Recommendations for monitoring systemic lupus erythematosus patients in clinical practice and in observational studies," Annals of the Rheumatic Diseases, 2009.
R. Bove, "Autoimmune diseases and reproductive aging," Clinical Immunology, vol. 149, no. 2, pp. 251-264, 2013.
C. C. Mok and C. S. Lau, "Pathogenesis of systemic lupus erythematosus," Journal of Clinical Pathology, vol. 56, no. 7, pp. 481-490, 2003.
M. H. van Beers-Tas, S. A. Turk, and D. van Schaardenburg, "How does established rheumatoid arthritis develop, and are there possibilities for prevention?" Best Practice & Research Clinical Rheumatology, vol. 29, no. 4-5, pp. 527-542, 2015.
T. J. Santoro, M. Tomita, and A. T. Masi, "Rheumatologic diseases and antiphospholipid syndrome," in Clinical Maternal-Fetal Medicine, CRC Press, 2021, pp. 18-1.
V. S. Vanni, R. De Lorenzo, L. Privitera, V. Canti, P. Viganò, and P. Rovere-Querini, "Safety of fertility treatments in women with systemic autoimmune diseases (SADs)," Expert Opinion on Drug Safety, vol. 18, no. 9, pp. 841-852, 2019.
S. A. Abraham, S. Begum, D. Isenberg, N. Ahmed, A. Bloch-Zupan, and K. J. Murray, "Bibliography Current World Literature Vol 17 No 2 March 2005," Ann Rheum Dis, vol. 63, pp. 123-129, 2004.
E. Ortona, M. Pierdominici, and V. Rider, "Sex hormones and gender differences in immune responses," Frontiers in Immunology, vol. 10, p. 1076, 2019.
Y. Shoenfeld and D. A. Isenberg, "The mosaic of autoimmunity," Immunology Today, vol. 10, no. 4, pp. 123-126, 1989.
Rojas-Villarraga, J. Amaya-Amaya, A. Rodriguez-Rodriguez, R. D. Mantilla, and J. M. Anaya, "Introducing poly autoimmunity: secondary autoimmune diseases no longer exist," Autoimmune Diseases, vol. 2012, p. 254319, 2012.
F. R. Brennan, "Monoclonal antibodies in phase 1 and 2 studies for immunological disorders," in Handbook of Therapeutic Antibodies, pp. 927-968, 2014.
S. A. Ahmed, W. J. Penhale, and N. Talal, "Sex hormones, immune responses, and autoimmune diseases," Mechanisms of Sex Hormone Action, The American Journal of Pathology, vol. 121, no. 3, pp. 531, 1985.
T. Männistö, P. Mendola, J. Grewal, Y. Xie, Z. Chen, and S. K. Laughon, "Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort," The Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 7, pp. 2725-2733, 2013.
T. I. Korevaar, A. Derakhshan, P. N. Taylor, M. Meima, L. Chen, S. Bliddal, et al., "Association of thyroid function test abnormalities and thyroid autoimmunity with preterm birth: a systematic review and meta-analysis," JAMA, vol. 322, no. 7, pp. 632-641, 2019.
W. Marder, et al., "The reproductive health of women with rheumatoid arthritis," Rheumatic Disease Clinics, vol. 38, no. 2, pp. 287-301, 2012.
